Sarepta Therapeutics, Inc.
Sarepta Therapeutics is a biopharmaceutical company focused on precision genetic medicine for rare diseases, with its primary political exposure stemming from $2.79M in annual physician payments and a single $7.7M federal contract.
BusinessWhat SRPT does
Sarepta Therapeutics develops and commercializes RNA-targeted therapeutics, gene therapies, and other genetic medicines for rare neuromuscular and central nervous system diseases. Its revenue is primarily driven by its marketed exon-skipping therapies for Duchenne muscular dystrophy (DMD). The company's pipeline includes gene therapy candidates for various genetic disorders.
12 months past · 3 months futureSRPT activity timeline
Lifetime Government AwardsSRPT federal contracts by year
Smart Money · 13F HoldingsHedge funds holding SRPT
Politicians Trading SRPTMembers of Congress with recent SRPT positions
Congressional TradesWho in Congress is trading SRPT
Corporate Insiders · Form 4What CEOs, CFOs, and directors are doing with their own stock
No Form 4 activity recorded in the last 180 days.
Political ProfileWhere SRPT sits in Washington
[object Object]
STRUCTURAL: High regulatory density (FDA) but no direct lobbying spend (`get_political_influence.lobbying.total_income`: $0) or aligned congressional champions. EVIDENTIARY: No insider buys in 180 days (`get_corporate_insider_signal.total_buys`: 0) and no congressional trades. A single federal contract exists (`get_government_precedent.federal_contracts_summary[0].total_obligation`: $7.7M). Net: Regulatory dependence dominates with no offsetting political capital.
Regulatory ExposureThreats & opportunities
Regulatory threats
-
Heightened FDA scrutiny on accelerated approvals and confirmatory trial requirements for rare disease therapies.U.S. Food and Drug Administration (FDA)"Inferred from sector; no specific bill impacts in `Recent bill_impacts`."
Regulatory opportunities
-
Potential for priority review vouchers and orphan drug exclusivity for pipeline candidates in rare diseases.U.S. Food and Drug Administration (FDA)"Inferred from sector; no specific bill carveouts in `Recent bill_carveouts`."
Live signals + predictions for SRPT — for Founders
The free page above gives you the public record. Members see the real-time intelligence layer on top of it:
- Live 7-layer signal scores when Congress trades SRPT
- Bill Pass Index v2 odds for every bill on the watch list
- Iron Triangle alerts (committee × donor × trade)
- SEC Form 4 cluster detection (CEO + CFO + director buys)
- Whale-Opportunity expected-value ranking
- Custom watchlist alerts via email + Discord